Organon (OGN) Shares Outstanding (Weighted Average) (2020 - 2026)

Organon's Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $260.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 0.97% year-over-year to $260.4 million; the TTM figure through Mar 2026 stood at $260.4 million (up 0.97% YoY), while the FY2025 annual figure was $259.5 million, up 0.95% from the prior year.
• Shares Outstanding (Weighted Average) was $260.4 million for Q1 2026 at Organon, roughly flat from $259.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $260.4 million in Q1 2026 to a low of $253.6 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $256.5 million across 5 years, with a median of $255.7 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) rose 0.03% in 2022, then rose 1.34% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $254.1 million in 2022, then advanced by 0.46% to $255.2 million in 2023, then climbed by 0.71% to $257.0 million in 2024, then rose by 0.95% to $259.5 million in 2025, then advanced by 0.34% to $260.4 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $260.4 million (Q1 2026), $259.5 million (Q4 2025), and $260.0 million (Q3 2025), per Business Quant data.